Notable therapeutic response in a patient with systemic juvenile xanthogranuloma with KIF5B‐ALK fusion
- 10 July 2021
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (11) , e29227
Abstract
No abstract availableKeywords
All Related Versions
This publication has 17 references indexed in Scilit:
- ALK-positive Histiocytosis of the BreastAmerican Journal of Surgical Pathology, 2020
- Long‐term outcomes of children with extracutaneous juvenile xanthogranulomas in JapanPediatric Blood & Cancer, 2020
- Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsNature Medicine, 2019
- Atypical juvenile histiocytosis with novel KIF5B-ALK gene fusion mimicking subglottic hemangiomaInternational Journal of Pediatric Otorhinolaryngology, 2019
- ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous systemActa Neuropathologica, 2019
- Congenital‐type juvenile xanthogranuloma: A case series and literature reviewPediatric Dermatology, 2018
- Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsCancer Discovery, 2016
- KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung CancerClinical Cancer Research, 2009
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994